• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Riluzole prescribing, uptake and treatment discontinuation in people with amyotrophic lateral sclerosis in Scotland.

作者信息

Jayaprakash Kiran, Glasmacher Stella A, Pang Bernard, Beswick Emily, Mehta Arpan R, Dakin Rachel, Newton Judith, Chandran Siddharthan, Pal Suvankar

机构信息

Centre for Clinical Brain Sciences, University of Edinburgh, Chancellor's Building, 49 Little France Crescent, Edinburgh, EH16 4SB, UK.

Anne Rowling Regenerative Neurology Clinic, Royal Infirmary, Edinburgh, UK.

出版信息

J Neurol. 2020 Aug;267(8):2459-2461. doi: 10.1007/s00415-020-09919-9. Epub 2020 May 23.

DOI:10.1007/s00415-020-09919-9
PMID:32447548
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7359150/
Abstract
摘要

相似文献

1
Riluzole prescribing, uptake and treatment discontinuation in people with amyotrophic lateral sclerosis in Scotland.苏格兰肌萎缩侧索硬化症患者的利鲁唑处方、使用情况及治疗中断情况
J Neurol. 2020 Aug;267(8):2459-2461. doi: 10.1007/s00415-020-09919-9. Epub 2020 May 23.
2
[Cotreatment of amyotrophic lateral sclerosis patients].[肌萎缩侧索硬化症患者的联合治疗]
Rinsho Shinkeigaku. 1999 Dec;39(12):1253-5.
3
A study of riluzole in the treatment of advanced stage or elderly patients with amyotrophic lateral sclerosis.利鲁唑治疗晚期或老年肌萎缩侧索硬化症患者的研究。
J Neurol. 2002 May;249(5):609-15. doi: 10.1007/s004150200071.
4
An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000.利鲁唑治疗肌萎缩侧索硬化症的疗效研究——1996 - 2000年爱尔兰的一项基于人群的研究
J Neurol. 2003 Apr;250(4):473-9. doi: 10.1007/s00415-003-1026-z.
5
Riluzole 5 mg/mL oral suspension: for optimized drug delivery in amyotrophic lateral sclerosis.利鲁唑5毫克/毫升口服混悬液：用于肌萎缩侧索硬化症的优化药物递送。
Drug Des Devel Ther. 2016 Dec 22;11:59-64. doi: 10.2147/DDDT.S123776. eCollection 2017.
6
Mecasin treatment in patients with amyotrophic lateral sclerosis: study protocol for a randomized controlled trial.肌萎缩侧索硬化症患者的美卡辛治疗：一项随机对照试验的研究方案
Trials. 2018 Apr 13;19(1):225. doi: 10.1186/s13063-018-2557-z.
7
Acute Effects of Riluzole and Retigabine on Axonal Excitability in Patients With Amyotrophic Lateral Sclerosis: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.利鲁唑和瑞替加滨对肌萎缩侧索硬化症患者轴突兴奋性的急性影响：一项随机、双盲、安慰剂对照、交叉试验。
Clin Pharmacol Ther. 2018 Dec;104(6):1136-1145. doi: 10.1002/cpt.1096. Epub 2018 Jun 19.
8
Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II.利鲁唑治疗肌萎缩侧索硬化的剂量范围研究。肌萎缩侧索硬化/利鲁唑研究组II。
Lancet. 1996 May 25;347(9013):1425-31. doi: 10.1016/s0140-6736(96)91680-3.
9
Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis.利鲁唑对肌萎缩侧索硬化症具有中枢和外周调节作用。
Brain. 2013 May;136(Pt 5):1361-70. doi: 10.1093/brain/awt085.
10
Verapamil and riluzole cocktail liposomes overcome pharmacoresistance by inhibiting P-glycoprotein in brain endothelial and astrocyte cells: A potent approach to treat amyotrophic lateral sclerosis.维拉帕米和利鲁唑鸡尾酒脂质体通过抑制脑内皮细胞和星形胶质细胞中的 P 糖蛋白克服多药耐药性：治疗肌萎缩侧索硬化症的有效方法。
Eur J Pharm Sci. 2018 Jul 30;120:30-39. doi: 10.1016/j.ejps.2018.04.026. Epub 2018 Apr 26.

引用本文的文献

1
Epidemiology, disease evolution and economic burden of amyotrophic lateral sclerosis in France using the French national health data system.利用法国国家卫生数据系统对法国肌萎缩侧索硬化症的流行病学、疾病演变及经济负担进行研究
Brain Commun. 2025 Aug 11;7(4):fcaf292. doi: 10.1093/braincomms/fcaf292. eCollection 2025.
2
Neuroprotective Riluzole-Releasing Electrospun Implants for Spinal Cord Injury.用于脊髓损伤的神经保护性利鲁唑释放电纺植入物。
Mol Pharm. 2025 Jun 2;22(6):2905-2916. doi: 10.1021/acs.molpharmaceut.4c01270. Epub 2025 May 16.
3
Pharmacological and non-pharmacological treatments in amyotrophic lateral sclerosis: an Italian real-world data study.

本文引用的文献

1
Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian National Motor Neuron Disease observational cohort.肌萎缩侧索硬化症/运动神经元病临床表型的识别与结局：澳大利亚国家运动神经元病观察队列研究
BMJ Open. 2016 Sep 30;6(9):e012054. doi: 10.1136/bmjopen-2016-012054.
2
A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?回顾力鲁唑治疗肌萎缩侧索硬化症的作用机制和临床疗效：在过去十年中我们学到了什么？
CNS Neurosci Ther. 2011 Feb;17(1):4-31. doi: 10.1111/j.1755-5949.2009.00116.x.
3
肌萎缩侧索硬化症的药物和非药物治疗：一项意大利真实世界数据研究。
Eur J Neurol. 2024 Dec;31(12):e16470. doi: 10.1111/ene.16470. Epub 2024 Sep 19.
4
Comparison of Demographics: National Amyotrophic Lateral Sclerosis Registry and Clinical Trials Data.人口统计学比较：国家肌萎缩侧索硬化症注册库与临床试验数据
J Racial Ethn Health Disparities. 2024 Jul 8. doi: 10.1007/s40615-024-02047-4.
5
Update on recent advances in amyotrophic lateral sclerosis.肌萎缩侧索硬化症的最新进展综述。
J Neurol. 2024 Jul;271(7):4693-4723. doi: 10.1007/s00415-024-12435-9. Epub 2024 May 27.
6
Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective.肌萎缩侧索硬化症的临床试验：系统评价与展望
Brain Commun. 2021 Oct 23;3(4):fcab242. doi: 10.1093/braincomms/fcab242. eCollection 2021.
7
Defining novel functions for cerebrospinal fluid in ALS pathophysiology.定义脑脊液在 ALS 病理生理学中的新功能。
Acta Neuropathol Commun. 2020 Aug 20;8(1):140. doi: 10.1186/s40478-020-01018-0.
Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy.
利鲁唑与肌萎缩侧索硬化症患者的生存情况：意大利南部的一项基于人群的研究。
Eur J Neurol. 2007 Mar;14(3):262-8. doi: 10.1111/j.1468-1331.2006.01575.x.
4
The ALS/MND prevalence in Sweden estimated by riluzole sales statistics.通过利鲁唑销售统计数据估算的瑞典肌萎缩侧索硬化症/运动神经元病患病率。
Acta Neurol Scand. 2005 Mar;111(3):180-4. doi: 10.1111/j.1600-0404.2005.00384.x.
5
The tolerability of riluzole in the treatment of patients with amyotrophic lateral sclerosis.利鲁唑治疗肌萎缩侧索硬化症患者的耐受性
Expert Opin Drug Saf. 2004 Nov;3(6):525-34. doi: 10.1517/14740338.3.6.525.
6
A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group.利鲁唑治疗肌萎缩侧索硬化症的对照试验。肌萎缩侧索硬化症/利鲁唑研究组
N Engl J Med. 1994 Mar 3;330(9):585-91. doi: 10.1056/NEJM199403033300901.